HPV (Human Papillomavirus) has largely been associated with disease in women. Recent findings show that HPV-16 in men has been associated with the development of penile, anal and oropharyngeal cancers. The latter has increased significantly in men over recent decades, with oropharyngeal cancer cases in men now surpassing those of cervical cancers in women. Unfortunately, most of these cases of HPV in men are diagnosed at advanced clinical stages (Stage III - IV), preventable with early screening.
Increasing HPV screening in males is a key objective in reducing missed clinical opportunities. The prevalence of HPV in men remains a challenge to healthcare systems around the world. The number of infected males remains under-estimated. Sadly, 52% of men have never heard of HPV. So, both education and screening for oral and penile HPV seems desirable and reasonable, with special attention given to screening for HPV-16. So don't be afraid. Be smart. Get tested!